Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-24
2010-02-09
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S350000, C546S199000, C549S059000
Reexamination Certificate
active
07659274
ABSTRACT:
Compounds represented by Formula (I)or a pharmaceutically acceptable salt thereof, are inhibitors of mTOR and useful in the treatment of cancer.
REFERENCES:
patent: 5869485 (1999-02-01), Missbach
patent: 6001839 (1999-12-01), Calderwood et al.
patent: 2002/0156081 (2002-10-01), Hirst et al.
patent: 2003/0073218 (2003-04-01), Shokat et al.
patent: 2003/0187001 (2003-10-01), Calderwood et al.
patent: 2005/0004142 (2005-01-01), Adams et al.
patent: 2005/0130994 (2005-06-01), Chen et al.
patent: 2006/0019957 (2006-01-01), Crew et al.
patent: 2006/0084654 (2006-04-01), Beck et al.
patent: 2006/0235031 (2006-10-01), Arnold et al.
patent: 2007/0112005 (2007-05-01), Chen et al.
patent: 2007/0149521 (2007-06-01), Crew et al.
patent: 2007/0167383 (2007-07-01), Roberts et al.
patent: 2007/0203143 (2007-08-01), Sheppard et al.
patent: 2007/0280928 (2007-12-01), Buck et al.
patent: 2007/0293516 (2007-12-01), Knight et al.
patent: 2008/0032960 (2008-02-01), Knight et al.
patent: 2009/0099174 (2009-04-01), Smith
patent: 2009/0124638 (2009-05-01), Shokat et al.
patent: 2007115620 (2007-10-01), None
patent: 2007126841 (2007-11-01), None
Bergstrom, D. et al. (1981) Journal of Organic Chemistry 46(7):1423-1431.
Bergstrom, D. et al. (1991) Journal of Organic Chemistry 56(19):5598-5602.
Bishop, A. et al. (1999) Journal of the American Chemical Society 121(4):627631.
Buzko, O. et al. (2002) Journal of Computer-Aided Design 16(2):113-127.
Hubbard, R.D. et al. (2007) Bioorganic & Medicinal Chemistry Letters 17(19):5406-5409.
International Preliminary Report on Patentability in PCT/US2006/044461.
International Search Report in PCT/US2006/044461.
International Search Report in PCT/US2007/002027.
Kinkade, C.W. et al. (2008) Journal of Clinical Investigation 118(9):3051-3064.
Legrier, M. et al. (2007) Cancer Research 67(23):11300-11308.
Papadimitrakopoulou, V. and Adjei, A.A. (2006) Journal of Thoracic Oncology 1(7): 749-751.
Prousek, J. (1984) Collection of Czechoslovak Chemical Communications 49(8):1788-1794.
Raslan, M.A. et al. (2000) Heteroatom Chemistry 11(2):94-201.
Seela, F. et al. (2000) Helvetica Chimica Acta 83(5):910-927.
Schram, K. et al. (1974) Journal of Carbohydrates, Nucleosides, Nucleotides 1(1):39-54.
Written Opinion of the International Search Authority in PCT/US2006/044461.
Written Opinion of the International Search Authority in PCT/US2007/002027.
Crew Andrew Philip
Tavares Paula A. R.
Werner Douglas S.
McDowell Brian
OSI Pharmaceuticals, Inc.
Wilson James O
LandOfFree
Unsaturated mTOR inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Unsaturated mTOR inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unsaturated mTOR inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218217